<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="correction">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2026.15830</article-id>
<article-id pub-id-type="publisher-id">OL-32-4-15830</article-id>
<article-categories>
<subj-group>
<subject>Corrigendum</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Corrigendum] Angiotensin II type 2 receptor-interacting protein 3a suppresses proliferation, migration and invasion in tongue squamous cell carcinoma via the extracellular signal-regulated kinase-Snai2 pathway</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Tingting</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>He</surname><given-names>Qianting</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Zhonghua</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Ding</surname><given-names>Xueqiang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Xiaofeng</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Anxun</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection"><month>10</month><year>2026</year></pub-date>
<pub-date pub-type="epub"><day>24</day><month>08</month><year>2026</year></pub-date>
<volume>32</volume>
<issue>4</issue>
<elocation-id>475</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Zhao et al.</copyright-statement>
<copyright-year>2026</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Lett 11: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="corrected-article" vol="11" page="340" id="RA1" xlink:href="10.3892/ol.2015.3898" ext-link-type="doi">340&#x2013;344</related-article>, 2016; DOI: 10.3892/ol.2015.3898</p>
<p>Following the publication of the above paper, an interested reader has drawn the Editor&#x0027;s attention to the fact that, regarding the cell invasion and migration assay data shown in <xref rid="f3-ol-32-4-15830" ref-type="fig">Fig. 3B and C</xref> respectively on p. 343, the &#x2018;ATIP3a siRNA&#x2019; data panel in <xref rid="f3-ol-32-4-15830" ref-type="fig">Fig. 3B</xref> and &#x2018;Control siRNA&#x2019; data panel in <xref rid="f3-ol-32-4-15830" ref-type="fig">Fig. 3C</xref> were apparently matching, suggesting that the data in this figure had been assembled incorrectly. Upon consulting the authors in this regard, they have realized that the representative fluorescence microscopy images of UM2 cells treated with control siRNA (corresponding to the migration experiment in <xref rid="f3-ol-32-4-15830" ref-type="fig">Fig. 3C</xref>) were incorrectly selected during the preparation of the final composite figure. Specifically, the representative Control siRNA-treated UM2 migration panel in <xref rid="f3-ol-32-4-15830" ref-type="fig">Fig. 3C</xref> had been inadvertently duplicated from the ATIP3a siRNA-treated UM2 invasion panel in <xref rid="f3-ol-32-4-15830" ref-type="fig">Fig. 3B</xref>.</p>
<p>The revised version of <xref rid="f3-ol-32-4-15830" ref-type="fig">Fig. 3</xref>, now featuring the correct data for the &#x2018;Control siRNA&#x2019; data panel in <xref rid="f3-ol-32-4-15830" ref-type="fig">Fig. 3C</xref>, is shown on the next page. The authors wish to point out that this error was confined to the representative fluorescence micrographs, and did not affect the corresponding cell-count quantification, statistical analyses, figure legend, interpretation or conclusions of the study. All the authors agree with the publication of this corrigendum, and they are grateful to the Editor of <italic>Oncology Letters</italic> for allowing them the opportunity to publish this. The authors also apologize to the readership for any confusion caused.</p>
</body>
<floats-group>
<fig id="f3-ol-32-4-15830" position="float">
<label>Figure 3.</label>
<caption><p>ATIP3a knockdown promoted the migration and invasion ability of tongue squamous cell carcinoma cells. (A) Significant reductions in ATIP3a protein levels were observed in the ATIP3a siRNA-transfected UM2 cells compared with the control siRNA-transfected cells. (B-D) ATIP3a knockdown promoted the (B) invasion, (C) migration and (D) proliferation ability of UM2 cells compared with that of the control siRNA-transfected UM2 cells. &#x002A;P&#x003C;0.05. ATIP3a, angiotensin II type 2 receptor-interacting protein 3a; siRNA, small interfering RNA; OD, optical density.</p></caption>
<alt-text>ATIP3a knockdown promoted the migration and invasion ability of tongue squamous cell carcinoma cells. (A) Significant reductions in ATIP3a protein levels were observed in the...</alt-text>
<graphic xlink:href="ol-32-04-15830-g00.jpg"/>
</fig>
</floats-group>
</article>
